Lastacaft Use In Pregnancy & Lactation




Full Prescribing Info
Use In Pregnancy & Lactation
Use in Pregnancy: Pregnancy Category B. Reproduction studies performed in rats and rabbits revealed no evidence of impaired female reproduction or harm to the fetus due to alcaftadine. Oral doses in rats and rabbits of 20 and 80 mg/kg/day, respectively, produced plasma exposure levels approximately 200 and 9000 times the plasma exposure at the recommended human ocular dose. There are however, no adequate and well controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Use in Lactation: There are no adequate data for the use of LASTACAFT during lactation. LASTACAFT should not be used during lactation unless the benefit to the mother and consequences of breast feeding interruption are taken into consideration.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in